Log In
BCIQ
Print this Print this
 

TauC3

  Manage Alerts
Collapse Summary General Information
Company Intellect Neurosciences Inc.
Description mAb against a neoepitope formed following the cleavage of intact tau protein by proteolytic apoptotic caspase enzymes to yield the smaller delta tau
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today